Menu

Blog

Jul 7, 2020

U.S. signs $450 million contract with Regeneron for COVID-19 therapy

Posted by in categories: biotech/medical, government

(Reuters) — The U.S. government signed a $450 million contract with Regeneron Pharmaceuticals Inc (REGN.O) for its potential COVID-19 antibody cocktail, the drugmaker said on Tuesday.

Leave a reply